BHD, TP53, and HNF1beta on chromosome 17 were studied in 92 cases of renal cell carcinoma (46 chromophobe, 19 clear cell, 18 oncocytoma, and nine papillary). Six, thirteen, and zero cases had, respectively BHD, TP53, and HNF1beta mutations, (84% mutations involved chromophobe), suggesting a role for BHD and TP53 in chromophobe subtype.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360004 | PMC |
| http://dx.doi.org/10.1038/sj.bjc.6603492 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Elucidating the mechanisms of Buyang Huanwu Decoction in treating chronic cerebral ischemia: A combined approach using network pharmacology, molecular docking, and in vivo validation.
Phytomedicine
September 2024
College of Basic Medical Sciences, Shanxi University of Chinese Medicine, Jinzhong, 030619, China; School of Fushan, Shanxi University of Chinese Medicine, Jinzhong, 030619, China. Electronic address:
Article Synopsis
- The study looked at how a traditional herbal medicine called Buyang Huanwu Decoction (BHD) helps treat brain problems caused by poor blood flow.
- Researchers used special tools to find important ingredients in BHD and how they connect to certain genes and diseases.
- They tested BHD on rats and found that it might help reduce inflammation and improve brain health by affecting specific pathways in the body.
Homologous recombination repair gene mutations in Malaysian prostate cancer patients.
Cell Mol Biol (Noisy-le-grand)
August 2022
Department of Pathology, Faculty of Medicine and Health Sciences, Putra Malaysia University, Serdang, Malaysia.
Genetic alterations in the homologous recombination repair (HRR) genes are associated with an increased risk of prostate cancer development, and patients harboring these mutations can benefit from targeted therapy. The main aim of this study is to identify genetic alterations in HRR genes as a potential target for targeted treatment. In this study, targeted next generation sequencing (NGS) is used to analyze mutations in the protein-coding regions of the 27 genes involved in HRR and mutations in hotspots of 5 cancer-associated genes in four FFPE samples and three blood samples from prostate cancer patients.
View Article and Find Full Text PDFExploring the Mechanism of Buyang Huanwu Decoction Alleviating Restenosis by Regulating VSMC Phenotype Switching and Proliferation by Network Pharmacology and Molecular Docking.
Curr Comput Aided Drug Des
May 2023
School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang, China.
Background: Buyang Huanwu Decoction (BHD) is used to regulate blood circulation and clear collaterals and is widely used in coronary heart disease. However, the active compounds and the mechanism of BHD used to treat restenosis are less understood.
Objective: The study aimed to explore the potential mechanism of Buyang Huanwu decoction BHD for the treatment of restenosis using network pharmacology and molecular docking experiments.
A Case Report of Leptomeningeal Myelomatosis and Rapid Improvement with Regimen Consisting of Daratumumab, Pomalidomide, Vincristine, Procarbazine, and Dexamethasone.
Case Rep Hematol
August 2022
Pantai Premier Pathology Sdn Bhd, Kuala Lumpur, Malaysia.
Central nervous system (CNS) involvement in multiple myeloma (MM) (MM-CNS) in the form of leptomeningeal myelomatosis or brain parenchyma plasmacytoma is rare, causing challenges in clinical diagnosis and treatment. We would like to report a case of leptomeningeal myelomatosis and illustrated the challeges. A 61-year-old man was diagnosed with MM with left paravertebral plasmacytoma, R-ISS II with high suspicion of double-hit MM, either biallelic aberrancy of TP53 or del(17p) and IGH aberrancy depending on the definition chosen, treated with lenalidomide-bortezomib-dexamethasone and local radiotherapy, later developed systemic relapse and progression to MM-CNS in the form of leptomeningeal myelomatosis.
View Article and Find Full Text PDFGenome-wide post-transcriptional regulation of bovine mammary gland response to Streptococcus uberis.
J Appl Genet
December 2022
Novocraft Technologies Sdn Bhd, Petaling Jaya, Malaysia.
MicroRNAs (miRNAs) as post-transcriptionally regulators of gene expression have been shown to be critical regulators to fine-tuning immune responses, besides their criteria for being an ideal biomarker. The regulatory role of miRNAs in responses to most mastitis-causing pathogens is not well understood. Gram-positive Streptococcus uberis (Str.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!